Bangladesh national influenza programme: influenza factsheet 2019

Bangladesh Influenza Surveillance – Landscape Analysis 2019 INFLUENZA FACTSHEET 2019 BANGLADESH National Influenza Programme Basic information (2019) Total population 165 409 5861 Children <5 years of age 15 826 9521 Under-5 mortality rate (per 1000 live births) 29.01 Life expectancy at birth (years) 72.72 Provinces/divisions/regions/zones 8 Districts 64 Total health expenditure (% of GDP) 2.601 Income level (World Bank) Lower middle3 1https://www.who.int/southeastasia/health-topics/immunization 2https://www.who.int/gho/publications/world_health_statistics/2020/en/ 3https://data.worldbank.org/ Influenza Like Illness (ILI) Surveillance Type of ILI surveillance Sentinel Sites involved in ILI surveillance Hospitals (outpatients) Clinical case definition used for ILI case ascertainment WHO 2014 Is laboratory confirmation sought in ILI cases? Yes, 5 cases per week Number of ILI surveillance sites 10 Number of states/districts covered by the surveillance system 10 % of the population covered by the surveillance system 30.7% Denominator used for ILI surveillance Number of outpatient visits Reporting frequency to the national level Monthly How are the data reported? Aggregated Form of the reporting tool Electronic Severe Acute Respiratory Infection (SARI) Surveillance Type of SARI surveillance Sentinel Sites involved in SARI surveillance Hospitals (inpatients) Clinical case definition used for SARI case ascertainment WHO 2014 Is laboratory confirmation sought in SARI cases? Yes, for all SARI cases Number of SARI surveillance sites 19 Number of states/districts covered by the surveillance system 19 % of the population covered by the surveillance system 42.5% Denominator used for SARI surveillance Number of inpatient visits Reporting frequency to the national level Monthly How are the data reported? Aggregated Form of the reporting tool Electronic Influenza Surveillance – Landscape Analysis 2019 Bangladesh Location of Influenza sentinel surveillance sites (as of December 2019) Epidemiological data (FluID) – Severe Acute Respiratory infections (SARI) Surveillance 0 0.2 0.4 0.6 0.8 1 1.2 0 50 100 150 200 250 1 5 9 13 18 22 26 30 34 38 42 46 50 2 6 10 14 18 22 26 30 34 38 42 46 50 1 5 9 13 17 21 25 29 33 37 41 45 49 2017 2018 2019 Pr op or tio n N um be r o f c as es SARI cases Proportion of SARI cases per 100 inpatients Plotted in R (ggplot2). Data source: FluMART, available at http://apps.who.int/flumart/ Intensive Care Unit (ICU) surveillance Does the country have surveillance for influenza in the ICU? No Is laboratory confirmation sought in ICU cases? - Is case-based information collected? - Mortality surveillance Is timely all-cause mortality data (i.e. within one month) available in the country? No Bangladesh Influenza Surveillance – Landscape Analysis 2019 Virological surveillance Does the country have virological surveillance? Yes Type of virological surveillance Sentinel – If sentinel, number of sites involved 19 Is epidemiological case information collected? Yes – If yes, are the laboratory results linked with epidemiological data? Yes Average number of virological samples processed per week 200 Are samples processed from ILI or SARI surveillance systems? Yes, also other systems in addition to ILI/SARI Does the country have virus isolation capacity? Yes Does the country have RT-PCR capacity? Yes – % laboratories that perform RT-PCR 100% – % RT-PCR laboratories that report to NIC 100% Does the country use rapid diagnostic testing for influenza surveillance? No Does the country have sequencing capacity? Yes Does the country test for other respiratory viruses? Yes Virological data (FluNet) 0 20 40 60 80 100 0 20 40 60 80 100 120 140 160 180 1 5 9 13 17 21 25 29 33 37 41 45 49 1 5 9 13 17 21 25 29 33 37 41 45 49 1 5 9 13 17 21 25 29 33 37 41 45 49 2017 2018 2019 % P os iti ve N um be r o f c as es A/H1N1pm09 A/H1N1 A/H3N2 A/H5N1 A (Unsubtyped) B Yamagata B Victoria B (Unsubtyped) % Positive Plotted in R (ggplot2). Data source: FluMART, available at http://apps.who.int/flumart/ National Influenza Centre Does the country have a National Influenza Centre (NIC) or national laboratory? Yes – NIC (since 2007) Assays routinely performed at the NIC or national laboratory RT-PCR, sequencing Does the NIC have – Virus isolation capability – Antigenic characterisation capability – Antiviral susceptibility testing capability – Sequencing capability Yes No No Yes Does the NIC test for other respiratory viruses? Yes – Respiratory syncytial virus (RSV), Human metapneumovirus (HMPV), Parainfluenza virus 1,2,3, Adenovirus 16, Middle East respiratory syndrome coronavirus (MERS-CoV), and other respiratory viruses. Does the country have a quality control plan? Yes Influenza Surveillance – Landscape Analysis 2019 Bangladesh For technical information, please contact: Dr Pushpa Ranjan Wijesinghe, Programme Area Manager (Infectious Hazard Management). Email: wijesinghep@who.int Does the country follow national biosafety and biosecurity policy guidelines? Yes Does the country forward samples to a WHO Collaborating Centre (CC)? Yes –US CDC, Atlanta, USA – How often? Three to Four times a year Reporting Frequency of national reports Monthly Are epidemiological and virological data integrated? Yes, both type of data integrated Reported via a website? Yes – http://www.iedcr.gov.bd Does the country report to FluID? – Year of beginning of reporting – Frequency of reporting Yes 2010 Weekly Does the country report to FluNet? – Year of beginning of reporting – Frequency of reporting Yes 2015 Weekly Are there fixed outbreak thresholds? No Level at which data are stored, managed and analysed National level Has formal training on data reporting and analysis been provided to surveillance and laboratory staff? – If yes, when? – Has a training session been planned? If yes, when? Yes 2016 No Vaccination Does the country have a formal seasonal influenza vaccination policy? No Has seasonal influenza been introduced in the public sector? – Year introduced – Recommended risk groups – Vaccination period – Northern/Southern hemisphere vaccine ? – Vaccine type No - - - - - Is seasonal influenza offered in the private sector? – Only offered to particular risk groups? – Vaccination period – Northern/Southern hemisphere vaccine ? – Vaccine type Yes No During the year Northern hemisphere vaccine Quadrivalent vaccine Is vaccine offered to Hajj and Umrah pilgrims? Yes Vaccine production capacity Yes Pandemic preparedness Does the country have a National Influenza Pandemic Preparedness Plan? – Year developed – Year last updated Yes 2006 2012 Has the country performed simulation exercises? Yes Are there laboratory testing strategies in place for different phases of an influenza pandemic? Yes Are there surge capacity plans? No Does the pandemic preparedness plan include a detailed National Pandemic Vaccine Deployment Plan? – Are there priority groups? No -